Newsroom

Newsroom

NeoGenomics Announces That Inivata Liquid Biopsy Subsidiary and Collaborators Have Published Clinical Validation Data for RaDaR™ Assay MRD Assay at AACR 2022

Press Release
Read More

NeoGenomics, Inc. Expands Its Global Strategic Partnership Initiatives with Biognosys AG on Multiple Next Generation Proteomics Solutions Supporting Biopharma R&D

Press Release
Read More

NeoGenomics Schedules its First Quarter 2022 Earnings Release for April 27, 2022

Press Release
Read More

Using Real-World Lab Data Insights to Improve Biomarker Testing in Lung Cancer

Blog
Read More

NeoGenomics Announces That Inivata Liquid Biopsy Subsidiary and Collaborators Have Published Clinical Validation Data for RaDaR™ Assay in Non-Small Cell Lung Cancer

Press Release
Read More

First CDx Approval for HLA Typing

Blog
Read More

Talking Cancer Blog: A Conversation with Holly Smithson, Athena CEO & Diversity Champion

Blog
Read More

NeoGenomics To Participate In Multiple Upcoming Institutional Investor Conferences

Press Release
Read More

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients